Next Article in Journal
Evaluation of the Anabolic, Aphrodisiac and Reproductive Activity of Anacyclus Pyrethrum DC in Male Rats
Previous Article in Journal
Rapid HPLC Analysis for Quantitative Determination of the Two Isomeric Triterpenic Acids, Oleanolic acid and Ursolic acid, in Plantago Major
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Article

Biotransformation of Artemisinin Mediated through Fungal Strains for Obtaining Derivatives with Novel Activities

1
Genetic Resources and Biotechnology Division, Central Institute of Medicinal and Aromatic Plants (Council of Scientific and Industrial Research), Lucknow–226015, India
2
Analytical Chemistry Division, Central Institute of Medicinal and Aromatic Plants (Council of Scientific and Industrial Research), Lucknow–226015, India
3
Process and Product Development (Industrial Technology Centre), Central Institute of Medicinal and Aromatic Plants (Council of Scientific and Industrial Research), Lucknow–226015, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(1), 87-96; https://doi.org/10.3797/scipharm.0803-15
Received: 19 March 2008 / Accepted: 7 January 2009 / Published: 8 January 2009
Artemisinin, a sesquiterpene lactone, is the active antimalarial constituent of Artemisia annua. Several fungal strains Saccharomyces cerevisiae, Aspergillus flavus, Aspergillus niger and Picchia pastoris were used to biotransform artemisinin. Among these strains, A. flavus was the only microorganism capable of transforming artemisinin to deoxyartemisinin in higher yields than the previous reports. The structure of deoxyartemisinin was elucidated by spectroscopy. Deoxyartemisinin showed antibacterial activity against Staphylococcus aureus, S. epidermidis and S. mutans at a minimum inhibitory concentration (MIC) of 1 mg/mL compared to artemisinin whose MIC was >2 mg/mL.
Keywords: Biotransformation; Artemisinin; Deoxyartemisinin; Aspergillus flavus; Antibacterial Biotransformation; Artemisinin; Deoxyartemisinin; Aspergillus flavus; Antibacterial
MDPI and ACS Style

SRIVASTAVA, S.; LUQMAN, S.; FATIMA, A.; DAROKAR, M.P.; NEGI, A.S.; KUMAR, J.K.; SHANKER, K.; CHANOTIYA, C.S.; TANDON, S.; KHANUJA, S.P.S. Biotransformation of Artemisinin Mediated through Fungal Strains for Obtaining Derivatives with Novel Activities. Sci. Pharm. 2009, 77, 87-96. https://doi.org/10.3797/scipharm.0803-15

AMA Style

SRIVASTAVA S, LUQMAN S, FATIMA A, DAROKAR MP, NEGI AS, KUMAR JK, SHANKER K, CHANOTIYA CS, TANDON S, KHANUJA SPS. Biotransformation of Artemisinin Mediated through Fungal Strains for Obtaining Derivatives with Novel Activities. Scientia Pharmaceutica. 2009; 77(1):87-96. https://doi.org/10.3797/scipharm.0803-15

Chicago/Turabian Style

SRIVASTAVA, Suchita, Suaib LUQMAN, Atiya FATIMA, Mahendra P. DAROKAR, Arvind S. NEGI, J. K. KUMAR, K. SHANKER, Chandan S. CHANOTIYA, Sudeep TANDON, and Suman P. S. KHANUJA. 2009. "Biotransformation of Artemisinin Mediated through Fungal Strains for Obtaining Derivatives with Novel Activities" Scientia Pharmaceutica 77, no. 1: 87-96. https://doi.org/10.3797/scipharm.0803-15

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop